Skip to main content
. 2022 Oct 17;10(4):90. doi: 10.3390/diseases10040090

Figure 3.

Figure 3

The HAT-pipeline at Swiss TPH established by the Parasite Chemotherapy Unit under the lead of Reto Brun. The one molecule that was singled out as the best drug candidate of all the tested nitro-drugs was fexinidazole.